Concepedia

Insiya Jafferji

IJ

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

2009

Affiliations

University of Cambridge(Current)

Wellcome Trust

Addenbrooke's Hospital

University of Nottingham

Nottingham City Hospital

Insiya Jafferji is an author at University of Cambridge specializing in oncology, immunology, and natural killer cell receptor nkg2d.

Publications per year

2009–2012

8

Publications

8

ApoStream™, a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood

Vishal Gupta, Insiya Jafferji, Miguel Garza et al. · Biomicrofluidics · 2012 · 379 citations · Full text

, , +17

NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting

Roger McGilvray, Robert A. Eagle, Nicholas FS Watson et al. · Clinical Cancer Research · 2009 · 191 citations · Full text

, , +17

NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study

Esther M. de Kruijf, Anita Sajet, Johanna GH van Nes et al. · BMC Cancer · 2012 · 126 citations · Full text

, , +17

ULBP6/RAET1L is an additional human NKG2D ligand

Robert A. Eagle, James A. Traherne, James Hair et al. · European Journal of Immunology · 2009 · 119 citations

, , +16

ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients

Roger McGilvray, Robert A. Eagle, Phil Rolland et al. · International Journal of Cancer · 2010 · 85 citations · Full text

, , +13

1–5 of 8